Drugs / Indirubin
Indirubin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01735864 Comparator | Nov 2012 → Apr 2014 | psoriasis | Chang Gung Memorial Hospital | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Indirubin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01735864 ↗ |
| Known as | C.I. 75790 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1276127 ↗ |
| Known as | Couroupitine b | ChEMBL registry synonym — accepted as the source's own label CHEMBL1276127 ↗ |
| Known as | NSC-105327 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1276127 ↗ |
| Modality | Small molecule | — CHEMBL1276127 ↗ |
| Route | Topical | “Dosing schedule: apply 0.5 g of ointment per 10 x 10 cm psoriatic lesion twice daily” NCT01735864 ↗ |